
The newly FDA-approved drug blocks viral replication and RNA transcription via a cap-dependent endonuclease inhibitor.

The newly FDA-approved drug blocks viral replication and RNA transcription via a cap-dependent endonuclease inhibitor.

Published: January 25th 2019 | Updated: